SAN DIEGO, March 30, 2017 /PRNewswire/ — Sherpa Clinical Packaging continues to invest in growth and infrastructure with its latest facility addition. The facility expansion will support continued growth in Sherpa’s packaging, labeling, and distribution services, especially as it relates to later stage projects and global studies. The new building will house four packaging suites, a class 100,000 cleanroom, and various temperature-controlled storage areas including expansive 2-8°C and -20°C rooms, and a Controlled Room Temperature warehouse. The new cGMP facility consists of 24,000 ft2 and is adjacent to Sherpa’s existing 38,000 ft2 headquarters.
In a statement on the expansion of Sherpa, President & Founder Mark Paiz said:
“I am extremely pleased to see so many of our customers moving into Phase II and III clinical trials. As the number of global clinical trials that Sherpa supports increases over the next few years, Sherpa’s expanded clinical supply offerings, partnerships and facilities are well poised to support this growth.”
Construction of the building has commenced and is expected to be completed by July, 2017.
In addition to facilities expansion, Sherpa expects to add significantly to its operations, quality, and project management teams within the next year.
About Sherpa Clinical Packaging
Sherpa Clinical Packaging is a privately-owned provider of clinical trial material management services for clinical studies phases I-IV, including packaging, labeling, distribution and returns/reconciliation, for pharmaceutical, biotechnology, medical device and dietary supplement companies. Sherpa is located in San Diego, California and partners with companies locally and globally. Sherpa distributes clinical supplies to hundreds of sites across the US, Canada, Europe and abroad. For more information, visit www.SherpaClinical.com.
Contact: Marisa Reinoso, email@example.com, 858-322-6023